These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 30157531)

  • 41. The Metabolic Effects of Oats Intake in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis.
    Hou Q; Li Y; Li L; Cheng G; Sun X; Li S; Tian H
    Nutrients; 2015 Dec; 7(12):10369-87. PubMed ID: 26690472
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Weight change upon once-daily initiation of insulin detemir with or without dietary intervention in overweight or obese insulin-naïve individuals with type 2 diabetes: results from the DIET trial.
    Niswender K; Piletic M; Andersen H; Conradsen Hiort L; Hollander P
    Diabetes Obes Metab; 2014 Feb; 16(2):186-92. PubMed ID: 24112375
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Beneficial effects of a Paleolithic diet on cardiovascular risk factors in type 2 diabetes: a randomized cross-over pilot study.
    Jönsson T; Granfeldt Y; Ahrén B; Branell UC; Pålsson G; Hansson A; Söderström M; Lindeberg S
    Cardiovasc Diabetol; 2009 Jul; 8():35. PubMed ID: 19604407
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Short-Term Dietary Oatmeal Interventions in Adults With Type 2 Diabetes: A Forgotten Tool.
    Storz MA; Iraci F
    Can J Diabetes; 2020 Jun; 44(4):301-303. PubMed ID: 31866240
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effects of metformin on glycemic control and serum lipids in insulin-treated NIDDM patients with suboptimal metabolic control.
    Robinson AC; Burke J; Robinson S; Johnston DG; Elkeles RS
    Diabetes Care; 1998 May; 21(5):701-5. PubMed ID: 9589227
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of vildagliptin twice daily vs. sitagliptin once daily using continuous glucose monitoring (CGM): crossover pilot study (J-VICTORIA study).
    Sakamoto M; Nishimura R; Irako T; Tsujino D; Ando K; Utsunomiya K
    Cardiovasc Diabetol; 2012 Aug; 11():92. PubMed ID: 22867630
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Insulin requirement profiles and related factors of insulin pump therapy in patients with type 2 diabetes.
    Yang X; Deng H; Zhang X; Yang D; Yan J; Yao B; Weng J; Xu W
    Sci China Life Sci; 2019 Nov; 62(11):1506-1513. PubMed ID: 31197759
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fasting until noon triggers increased postprandial hyperglycemia and impaired insulin response after lunch and dinner in individuals with type 2 diabetes: a randomized clinical trial.
    Jakubowicz D; Wainstein J; Ahren B; Landau Z; Bar-Dayan Y; Froy O
    Diabetes Care; 2015 Oct; 38(10):1820-6. PubMed ID: 26220945
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Addition of neutral protamine lispro insulin or insulin glargine to oral type 2 diabetes regimens for patients with suboptimal glycemic control: a randomized trial.
    Esposito K; Ciotola M; Maiorino MI; Gualdiero R; Schisano B; Ceriello A; Beneduce F; Feola G; Giugliano D
    Ann Intern Med; 2008 Oct; 149(8):531-9. PubMed ID: 18936501
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Soluble fibers from psyllium improve glycemic response and body weight among diabetes type 2 patients (randomized control trial).
    Abutair AS; Naser IA; Hamed AT
    Nutr J; 2016 Oct; 15(1):86. PubMed ID: 27733151
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Postprandial blood glucose response to a standard test meal in insulin-requiring patients with diabetes treated with insulin lispro mix 50 or human insulin mix 50.
    Gao Y; Li G; Li Y; Guo X; Yuan G; Gong Q; Yan L; Zheng Y; Zhang J
    Int J Clin Pract; 2008 Sep; 62(9):1344-51. PubMed ID: 18657196
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Short- and Long-Term Effects of Wholegrain Oat Intake on Weight Management and Glucolipid Metabolism in Overweight Type-2 Diabetics: A Randomized Control Trial.
    Li X; Cai X; Ma X; Jing L; Gu J; Bao L; Li J; Xu M; Zhang Z; Li Y
    Nutrients; 2016 Sep; 8(9):. PubMed ID: 27618090
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes: a randomized trial.
    Heine RJ; Van Gaal LF; Johns D; Mihm MJ; Widel MH; Brodows RG;
    Ann Intern Med; 2005 Oct; 143(8):559-69. PubMed ID: 16230722
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    Lo C; Jun M; Badve SV; Pilmore H; White SL; Hawley C; Cass A; Perkovic V; Zoungas S
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD009966. PubMed ID: 28238223
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of the efficacy and safety of once-daily insulin degludec/insulin aspart (IDegAsp) and long-acting second-generation basal insulin (insulin degludec and insulin glargine 300 units/mL) in insulin-naïve Japanese adults with type 2 diabetes: a pilot, randomized, controlled study.
    Shimoda S; Sakamoto W; Hokamura A; Matsuo Y; Sekigami T; Ichimori S; Iwashita S; Ishii N; Otsu K; Yoshimura R; Nishiyama T; Sakaguchi M; Nishida K; Araki E
    Endocr J; 2019 Aug; 66(8):745-752. PubMed ID: 31308304
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of personalized diets by prediction of glycemic responses on glycemic control and metabolic health in newly diagnosed T2DM: a randomized dietary intervention pilot trial.
    Rein M; Ben-Yacov O; Godneva A; Shilo S; Zmora N; Kolobkov D; Cohen-Dolev N; Wolf BC; Kosower N; Lotan-Pompan M; Weinberger A; Halpern Z; Zelber-Sagi S; Elinav E; Segal E
    BMC Med; 2022 Feb; 20(1):56. PubMed ID: 35135549
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of biphasic insulin aspart 30 given three times daily or twice daily in combination with metformin versus oral antidiabetic drugs alone in patients with poorly controlled type 2 diabetes: a 16-week, randomized, open-label, parallel-group trial conducted in russia.
    Ushakova O; Sokolovskaya V; Morozova A; Valeeva F; Zanozina O; Sazonova O; Zhadanova E; Starceva M; Kazakova E; Saifullina M; Shapiro I; Tarasov A; Al-Tayar B; Starkova N
    Clin Ther; 2007 Nov; 29(11):2374-84. PubMed ID: 18158078
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Continuous glucose monitoring with Humalog Mix 25 versus Humalog Mix 50, twice daily: a comparative pilot study -results from the Jikei-EValuation of insulin Lispro mixture on pharmacodynamics and glycemic VariancE (J-EVOLVE) study.
    Nishimura R; Tsujino D; Taki K; Morimoto A; Tajima N
    Cardiovasc Diabetol; 2010 May; 9():16. PubMed ID: 20438630
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Twice-daily pre-mixed insulin rather than basal insulin therapy alone results in better overall glycaemic control in patients with Type 2 diabetes.
    Malone JK; Bai S; Campaigne BN; Reviriego J; Augendre-Ferrante B
    Diabet Med; 2005 Apr; 22(4):374-81. PubMed ID: 15787659
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Long-term efficacy of dapagliflozin in patients with type 2 diabetes mellitus receiving high doses of insulin].
    Wilding JP; Woo V; Soler NG; Pahor A; Sugg J; Rohwedder K; Parikh S;
    Dtsch Med Wochenschr; 2013 Apr; 138 Suppl 1():S27-38. PubMed ID: 23529568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.